2024-2028年全球生物電子製藥市場

預計2023-2028年生物電醫學市場將成長77.7469億美元，預測期內複合年成長率為6.09%。

該報告包括對生物電醫學市場的總體分析、市場規模和預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

它提供了對當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。神經系統疾病盛行率的增加、心血管疾病的增加、FDA 對生物電藥物的核准增加等正在推動市場的發展。

研究指出，與神經系統疾病相關的擴大研究是推動未來幾年生物電子醫學市場成長的關鍵因素之一。報告也指出，生物電製藥廠商加強研發力度以及廠商之間戰略聯盟的增加將帶來強勁的市場需求。

目錄

第1章執行摘要

• 市場概況

第2章 市場狀況

• 市場生態系統

第3章 市場規模評估

• 市場定義
• 細分市場分析
• 2023 年市場規模
• 2023-2028年市場展望

第4章 市場規模表現

• 2018-2022年全球生物電子製藥市場
• 2018-2022 年按類型分類的細分市場分析
• 2018-2022 年按應用分類的細分市場分析
• 2018-2022 年區域細分分析
• 2018-2022 年國家細分分析

第5章五力分析

• 五力摘要
• 買方議價能力
• 供應商的議價能力
• 新進入者的威脅
• 替代品的威脅
• 競爭威脅
• 市場狀況

第6章市場細分：按類型

• 市場區隔
• 比較：按類型
• 植入式設備：2023-2028 年市場規模與預測
• 非侵入式設備：2023-2028 年市場規模與預測
• 市場機會：按類型

第7章 市場區隔：依應用

• 市場區隔
• 比較：按應用
• 心律不整：2023-2028 年市場規模與預測
• 癲癇：2023-2028 年市場規模與預測
• 帕金森氏症：2023-2028 年市場規模與預測
• Tremor：2023-2028 年市場規模與預測
• 其他：2023-2028年市場規模與預測
• 市場機會：依應用分類

第8章 客戶狀況

• 客戶狀況概覽

第9章 地區情勢

• 區域細分
• 區域比較
• 北美：2023-2028 年市場規模與預測
• 歐洲：2023-2028 年市場規模與預測
• 亞洲：2023-2028年市場規模與預測
• 世界其他地區：2023-2028 年市場規模與預測
• 美國：2023-2028 年市場規模與預測
• 德國：2023-2028年市場規模與預測
• 中國：2023-2028年市場規模及預測
• 英國：2023-2028 年市場規模與預測
• 日本：2023-2028年市場規模與預測
• 市場機會：按地區

第 10 章 促進因素、挑戰與趨勢

• 市場促進因素
• 市場挑戰
• 促進因素和挑戰的影響
• 市場趨勢

第11章 供應商情況

• 概述
• 供應商情況
• 混亂的情況
• 產業風險

第12章供應商分析

• 交易廠商
• 供應商市場定位
• Abbott Laboratories
• ALEVA NEUROTHERAPEUTICS SA
• Bayer AG
• Boston Scientific Corporation
• electroCore Inc.
• EndoStim Inc
• LivaNova PLC
• Medtronic
• NeuroMetrix Inc.
• NEURONETICS Inc.
• NeuroPace Inc.
• Nevro Corp.
• Patricia Industries
• Soterix Medical Inc.
• Synapse Biomedical Inc.

第13章附錄

The electroceutical bioelectric medicine market is forecasted to grow by USD 7774.69 mn during 2023-2028, accelerating AT a CAGR of 6.09% during the forecast period. The report on the electroceutical bioelectric medicine market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of neurological disorders, increasing cardiovascular disorders, and increasing fda approval for electroceutical bioelectric medicine.

Technavio's electroceutical bioelectric medicine market is segmented as below:

By Type

• Implantable devices
• Non-invasive devices

By Application

• Arrhythmia
• Epilepsy
• Parkinsons disease
• Tremors
• Others

By Geography

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the growing research related to neurological diseases as one of the prime reasons driving the electroceutical bioelectric medicine market growth during the next few years. Also, strengthening R and D on electroceutical bioelectric medicine by vendors and increasing strategic alliances between vendors will lead to sizable demand in the market.

The report on the electroceutical bioelectric medicine market covers the following areas:

• Electroceutical bioelectric medicine market sizing
• Electroceutical bioelectric medicine market forecast
• Electroceutical bioelectric medicine market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading electroceutical bioelectric medicine market vendors that include Abbott Laboratories, ALEVA NEUROTHERAPEUTICS SA, Bayer AG, Boston Scientific Corporation, Cochlear Ltd., Demant AS, electroCore Inc., EndoStim Inc, LivaNova PLC, MED EL Elektromedizinische Gerate GmbH, Medtronic, NeuroMetrix Inc., NEURONETICS Inc., NeuroPace Inc., Nevro Corp., Patricia Industries, Sonova Holding AG, Soterix Medical Inc., Synapse Biomedical Inc., and ZHEJIANG NUROTRON BIOTECHNOLOGY CO. LTD.. Also, the electroceutical bioelectric medicine market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. IT presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview

2 Market Landscape

• 2.1 Market ecosystem

3 Market Sizing

• 3.1 Market definition
• 3.2 Market segment analysis
• 3.3 Market size 2023
• 3.4 Market outlook: Forecast for 2023-2028

4 Historic Market Size

• 4.1 Global electroceutical bioelectric medicine market 2018 - 2022
• 4.2 Type Segment Analysis 2018 - 2022
• 4.3 Application Segment Analysis 2018 - 2022
• 4.4 Geography Segment Analysis 2018 - 2022
• 4.5 Country Segment Analysis 2018 - 2022

5 Five Forces Analysis

• 5.1 Five forces summary
• 5.2 Bargaining power of buyers
• 5.3 Bargaining power of suppliers
• 5.4 Threat of new entrants
• 5.5 Threat of substitutes
• 5.6 Threat of rivalry
• 5.7 Market condition

6 Market Segmentation by Type

• 6.1 Market segments
• 6.2 Comparison by Type
• 6.3 Implantable devices - Market size and forecast 2023-2028
• 6.4 Non-invasive devices - Market size and forecast 2023-2028
• 6.5 Market opportunity by Type

7 Market Segmentation by Application

• 7.1 Market segments
• 7.2 Comparison by Application
• 7.3 Arrhythmia - Market size and forecast 2023-2028
• 7.4 Epilepsy - Market size and forecast 2023-2028
• 7.5 Parkinsons disease - Market size and forecast 2023-2028
• 7.6 Tremors - Market size and forecast 2023-2028
• 7.7 Others - Market size and forecast 2023-2028
• 7.8 Market opportunity by Application

8 Customer Landscape

• 8.1 Customer landscape overview

9 Geographic Landscape

• 9.1 Geographic segmentation
• 9.2 Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
• 9.4 Europe - Market size and forecast 2023-2028
• 9.5 Asia - Market size and forecast 2023-2028
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
• 9.7 US - Market size and forecast 2023-2028
• 9.8 Germany - Market size and forecast 2023-2028
• 9.9 China - Market size and forecast 2023-2028
• 9.10 UK - Market size and forecast 2023-2028
• 9.11 Japan - Market size and forecast 2023-2028
• 9.12 Market opportunity by geography

10 Drivers, Challenges, and Trends

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
• 10.4 Market trends

11 Vendor Landscape

• 11.1 Overview
• 11.2 Vendor landscape
• 11.3 Landscape disruption
• 11.4 Industry risks

12 Vendor Analysis

• 12.1 Vendors covered
• 12.2 Market positioning of vendors
• 12.3 Abbott Laboratories
• 12.4 ALEVA NEUROTHERAPEUTICS SA
• 12.5 Bayer AG
• 12.6 Boston Scientific Corporation
• 12.7 electroCore Inc.
• 12.8 EndoStim Inc
• 12.9 LivaNova PLC
• 12.10 Medtronic
• 12.11 NeuroMetrix Inc.
• 12.12 NEURONETICS Inc.
• 12.13 NeuroPace Inc.
• 12.14 Nevro Corp.
• 12.15 Patricia Industries
• 12.16 Soterix Medical Inc.
• 12.17 Synapse Biomedical Inc.

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
• 13.3 Currency conversion rates for US$
• 13.4 Research methodology
• 13.5 List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market by Geography
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Market Segmentation by Application
• Exhibits7: Executive Summary - Chart on Incremental Growth
• Exhibits8: Executive Summary - Data Table on Incremental Growth
• Exhibits9: Executive Summary - Chart on Vendor Market Positioning
• Exhibits10: Parent market
• Exhibits11: Market Characteristics
• Exhibits12: Offerings of vendors included in the market definition
• Exhibits13: Market segments
• Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits18: Historic Market Size - Data Table on global electroceutical bioelectric medicine market 2018 - 2022 ($ million)
• Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
• Exhibits20: Historic Market Size - Application Segment 2018 - 2022 ($ million)
• Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits23: Five forces analysis - Comparison between 2023 and 2028
• Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits29: Chart on Market condition - Five forces 2023 and 2028
• Exhibits30: Chart on Type - Market share 2023-2028 (%)
• Exhibits31: Data Table on Type - Market share 2023-2028 (%)
• Exhibits32: Chart on Comparison by Type
• Exhibits33: Data Table on Comparison by Type
• Exhibits34: Chart on Implantable devices - Market size and forecast 2023-2028 ($ million)
• Exhibits35: Data Table on Implantable devices - Market size and forecast 2023-2028 ($ million)
• Exhibits36: Chart on Implantable devices - Year-over-year growth 2023-2028 (%)
• Exhibits37: Data Table on Implantable devices - Year-over-year growth 2023-2028 (%)
• Exhibits38: Chart on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Non-invasive devices - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Non-invasive devices - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Non-invasive devices - Year-over-year growth 2023-2028 (%)
• Exhibits42: Market opportunity by Type ($ million)
• Exhibits43: Data Table on Market opportunity by Type ($ million)
• Exhibits44: Chart on Application - Market share 2023-2028 (%)
• Exhibits45: Data Table on Application - Market share 2023-2028 (%)
• Exhibits46: Chart on Comparison by Application
• Exhibits47: Data Table on Comparison by Application
• Exhibits48: Chart on Arrhythmia - Market size and forecast 2023-2028 ($ million)
• Exhibits49: Data Table on Arrhythmia - Market size and forecast 2023-2028 ($ million)
• Exhibits50: Chart on Arrhythmia - Year-over-year growth 2023-2028 (%)
• Exhibits51: Data Table on Arrhythmia - Year-over-year growth 2023-2028 (%)
• Exhibits52: Chart on Epilepsy - Market size and forecast 2023-2028 ($ million)
• Exhibits53: Data Table on Epilepsy - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Chart on Epilepsy - Year-over-year growth 2023-2028 (%)
• Exhibits55: Data Table on Epilepsy - Year-over-year growth 2023-2028 (%)
• Exhibits56: Chart on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
• Exhibits57: Data Table on Parkinsons disease - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Chart on Parkinsons disease - Year-over-year growth 2023-2028 (%)
• Exhibits59: Data Table on Parkinsons disease - Year-over-year growth 2023-2028 (%)
• Exhibits60: Chart on Tremors - Market size and forecast 2023-2028 ($ million)
• Exhibits61: Data Table on Tremors - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Chart on Tremors - Year-over-year growth 2023-2028 (%)
• Exhibits63: Data Table on Tremors - Year-over-year growth 2023-2028 (%)
• Exhibits64: Chart on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits65: Data Table on Others - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Chart on Others - Year-over-year growth 2023-2028 (%)
• Exhibits67: Data Table on Others - Year-over-year growth 2023-2028 (%)
• Exhibits68: Market opportunity by Application ($ million)
• Exhibits69: Data Table on Market opportunity by Application ($ million)
• Exhibits70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits71: Chart on Market share by geography 2023-2028 (%)
• Exhibits72: Data Table on Market share by geography 2023-2028 (%)
• Exhibits73: Chart on Geographic comparison
• Exhibits74: Data Table on Geographic comparison
• Exhibits75: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits76: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits77: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits78: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits79: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits80: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits81: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits82: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits83: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits84: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits85: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits86: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits87: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits88: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits89: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits90: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits91: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits92: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits93: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits94: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
• Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
• Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits103: Chart on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits104: Data Table on UK - Market size and forecast 2023-2028 ($ million)
• Exhibits105: Chart on UK - Year-over-year growth 2023-2028 (%)
• Exhibits106: Data Table on UK - Year-over-year growth 2023-2028 (%)
• Exhibits107: Chart on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits108: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
• Exhibits109: Chart on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits110: Data Table on Japan - Year-over-year growth 2023-2028 (%)
• Exhibits111: Market opportunity by geography ($ million)
• Exhibits112: Data Tables on Market opportunity by geography ($ million)
• Exhibits113: Impact of drivers and challenges in 2023 and 2028
• Exhibits114: Overview on Criticality of inputs and Factors of differentiation
• Exhibits115: Overview on factors of disruption
• Exhibits116: Impact of key risks on business
• Exhibits117: Vendors covered
• Exhibits118: Matrix on vendor position and classification
• Exhibits119: Abbott Laboratories - Overview
• Exhibits120: Abbott Laboratories - Business segments
• Exhibits121: Abbott Laboratories - Key offerings
• Exhibits122: Abbott Laboratories - Segment focus
• Exhibits123: ALEVA NEUROTHERAPEUTICS SA - Overview
• Exhibits124: ALEVA NEUROTHERAPEUTICS SA - Product / Service
• Exhibits125: ALEVA NEUROTHERAPEUTICS SA - Key offerings
• Exhibits126: Bayer AG - Overview
• Exhibits127: Bayer AG - Business segments
• Exhibits128: Bayer AG - Key news
• Exhibits129: Bayer AG - Key offerings
• Exhibits130: Bayer AG - Segment focus
• Exhibits131: Boston Scientific Corporation - Overview
• Exhibits132: Boston Scientific Corporation - Business segments
• Exhibits133: Boston Scientific Corporation - Key news
• Exhibits134: Boston Scientific Corporation - Key offerings
• Exhibits135: Boston Scientific Corporation - Segment focus
• Exhibits136: electroCore Inc. - Overview
• Exhibits137: electroCore Inc. - Product / Service
• Exhibits138: electroCore Inc. - Key offerings
• Exhibits139: EndoStim Inc - Overview
• Exhibits140: EndoStim Inc - Product / Service
• Exhibits141: EndoStim Inc - Key offerings
• Exhibits142: LivaNova PLC - Overview
• Exhibits143: LivaNova PLC - Business segments
• Exhibits144: LivaNova PLC - Key news
• Exhibits145: LivaNova PLC - Key offerings
• Exhibits146: LivaNova PLC - Segment focus
• Exhibits147: Medtronic - Overview
• Exhibits148: Medtronic - Business segments
• Exhibits149: Medtronic - Key news
• Exhibits150: Medtronic - Key offerings
• Exhibits151: Medtronic - Segment focus
• Exhibits152: NeuroMetrix Inc. - Overview
• Exhibits153: NeuroMetrix Inc. - Product / Service
• Exhibits154: NeuroMetrix Inc. - Key offerings
• Exhibits155: NEURONETICS Inc. - Overview
• Exhibits156: NEURONETICS Inc. - Product / Service
• Exhibits157: NEURONETICS Inc. - Key offerings
• Exhibits158: NeuroPace Inc. - Overview
• Exhibits159: NeuroPace Inc. - Product / Service
• Exhibits160: NeuroPace Inc. - Key offerings
• Exhibits161: Nevro Corp. - Overview
• Exhibits162: Nevro Corp. - Product / Service
• Exhibits163: Nevro Corp. - Key offerings
• Exhibits164: Patricia Industries - Overview
• Exhibits165: Patricia Industries - Product / Service
• Exhibits166: Patricia Industries - Key offerings
• Exhibits167: Soterix Medical Inc. - Overview
• Exhibits168: Soterix Medical Inc. - Product / Service
• Exhibits169: Soterix Medical Inc. - Key offerings
• Exhibits170: Synapse Biomedical Inc. - Overview
• Exhibits171: Synapse Biomedical Inc. - Product / Service
• Exhibits172: Synapse Biomedical Inc. - Key offerings
• Exhibits173: Inclusions checklist
• Exhibits174: Exclusions checklist
• Exhibits175: Currency conversion rates for US$
• Exhibits176: Research methodology
• Exhibits177: Validation techniques employed for market sizing
• Exhibits178: Information sources
• Exhibits179: List of abbreviations